Name: Postprandial Glucose Spikes: Normal Physiology, Not a Disease to Flatten
Creator: Realised
Published: 2026-06-01

Summary

In a metabolically healthy person a post-meal glucose rise is normal physiology, not a problem to "flatten" — peaks to ~140 mg/dL (7.8 mmol/L), and transient excursions to 160–180, are typical and clear within 2–3 hours — and the real metabolic signal is the trajectory and the integrated picture (HbA1c, fasting insulin/HOMA-IR, a pattern of high responses), NOT the height of any single spike; the viral "spike anxiety" framing inverts this, treating every transient bump as pathology and selling flattening "hacks" whose evidence comes from diabetics, not the healthy audience being marketed to.

Why Moderate

Tier 2 (Moderate) because the load-bearing claims rest on solid but not gold-standard evidence: the normative-magnitude data (PMC10973852) are observational CGM profiles; the "spikes don't harm healthy people" verdict is a scoping review plus convergent expert opinion rather than a powered outcome trial; and the mechanism-to-outcome link is biomarker-level with two null CVD studies. The genuine "spikes matter" signal (1-hour OGTT ≥155) is Tier 1–2 strong but applies to impaired tolerance, not the healthy-person spike the entry is mostly correcting.

NOT Tier 1 because there's no powered outcome trial settling whether transient spikes harm healthy people; the verdict is "no demonstrated harm," which is an absence-of-evidence position anchored on a scoping review and expert convergence.
NOT Tier 3 because the normative magnitude is well characterised, the impaired-tolerance signal is robust, and the cui-bono and evidence weight converge clearly — this is more than emerging.

Practical takeaway

• If you're metabolically healthy, don't treat a post-meal rise as a problem to flatten. A peak to ~140 mg/dL (with transient excursions to 160–180) that settles within 2–3 hours is normal. You don't need to "fix" it.
• For a real metabolic read, look at the integrated markers, not a single CGM trace: HbA1c, fasting insulin and HOMA-IR — or a 1-hour OGTT if you're risk-screening. These predict outcomes; an isolated spike does not (biomarker_tracking).
• **Know the flags that mean a glucose response does matter:** a repeatedly high or slow-to-clear pattern, a 1-hour OGTT ≥155 mg/dL, a rising HbA1c, or family-history/impaired-glucose-tolerance risk. That's a see-a-clinician / screen-for-prediabetes flag — not a buy-vinegar flag.
• Be skeptical of spike-flattening "hacks" sold to healthy people (vinegar shots, mulberry, berberine, eating-order rules). Their evidence comes largely from diabetic populations and the effect sizes are small and short-term; they're low-risk but mostly solve a non-problem.
• Watch spike anxiety as a harm in its own right. Continuous glucose monitoring in healthy people has no outcome evidence and a documented downside in food anxiety and disordered-eating/orthorexia risk (cgm_in_non_diabetics). The fix is rarely more monitoring.
• The genuinely protective behaviours are the unglamorous ones that move HbA1c and insulin sensitivity: adequate fibre and whole foods, post-meal movement (post_meal_walks_glucose), sleep, and not being chronically overfed — not curve-flattening per meal (blood_sugar_regulation).

Evidence detail

Why This Entry Exists

A normal physiological response got rebranded as a disease. The "Glucose Goddess" wave on Instagram and TikTok took the ordinary post-meal rise that happens in everyone who eats and turned it into a thing to fear, monitor, and "hack" — with vinegar shots, eating-order rules, and a continuous glucose monitor strapped to the arm of someone who has no glucose problem at all. The framing is sticky because a graph with a tall peak looks alarming, and because a long line of products (CGMs, supplements, books) sells the cure for the fear.

The honest picture: in healthy people a peak to ~140 mg/dL that settles in a couple of hours is exactly what a functioning metabolism does. Where glucose responses genuinely matter, they matter as a pattern of impaired tolerance — a repeatedly high or slow-to-clear curve, a 1-hour OGTT ≥155 mg/dL, a rising HbA1c — not as one tall bar after a bowl of white rice. So this entry exists to do two jobs: defend the part that's real (sustained or pattern-level high responses are a genuine prediabetes signal worth screening) and dismantle the part that's marketing (transient spikes in healthy people as a demonstrated harm).

What bad advice this protects against, both ways:
• "Every glucose spike is damaging you — flatten the curve at every meal" → spike anxiety, food restriction, orthorexia risk, and a CGM you don't need.
• "Glucose is the root cause — fix your spikes and you fix your health" → a single downstream signal mistaken for the master lever; health is multifactorial.
• "Spikes don't exist / blood sugar is a scam" → the opposite overcorrection; a sustained high response or a high 1-hour OGTT is a real, well-evidenced prediabetes signal that should not be waved away.

It does not own the underlying metabolic biology (insulin_resistance_and_metabolic_dysfunction), the lifestyle-first glycaemic approach (blood_sugar_regulation), the CGM-in-healthy-people decision (cgm_in_non_diabetics), or any single flattening tactic (post_meal_walks_glucose). It owns the interpretation question: is a post-meal spike a problem, and when does a glucose response actually matter?

Evidence

1. The normative magnitude is well characterised — and a spike to ~140 is normal (Tier 2, load-bearing). In healthy non-diabetic adults on CGM with fixed meal times, median 24-hour glucose was ~95 mg/dL, median peak postprandial ~140 mg/dL (IQR 127–157), 90th-percentile peak ~174 mg/dL, time-to-peak ~50 minutes, median post-meal rise ~47 mg/dL, and participants spent ~93–96% of time in the 70–140 mg/dL (3.9–7.8 mmol/L) range (Continuous Glucose Profiles in Healthy People With Fixed Meal Times, PMC10973852, 2024). Crucially, peaks of 160–180 mg/dL "occurred regularly" in these healthy people. A tall bar on the graph is not the same as a problem.

2. A transient rise without sustained elevation is physiology, not pathology (Tier 2). A post-meal rise of 2–3 mmol/L — even peaking near 11 mmol/L briefly — that returns to baseline, without sustained elevation, is the normal behaviour of a working metabolism (McGill Office for Science and Society; Dr. Tsoukas). Sustained readings above ~11 mmol/L are the impaired-tolerance/diabetes sign — that's the line, not the height of one peak.

3. Where glucose responses genuinely matter: the 1-hour OGTT pattern (Tier 1–2). A 1-hour post-load glucose ≥155 mg/dL during an OGTT is a strong independent predictor of progression to type 2 diabetes — outperforming fasting glucose, 2-hour glucose, and HbA1c alone — and tracks with reduced beta-cell function, insulin resistance, NAFLD, vascular stiffness, and early atherosclerosis even when 2-hour glucose is below 140 (Bergman et al., JCEM 2018). This is the load-bearing "spikes can matter" finding — but note it is a pattern/impaired-tolerance signal under a standardised glucose load, not a one-off meal spike in a healthy person.

4. The integrated marker beats the isolated snapshot (Tier 2). Visit-to-visit HbA1c variability independently predicts macro- and microvascular events in the general (including non-diabetic) population, whereas fasting-glucose variability often does not (Nature Scientific Reports 2019 / PMC6362217). The signal lives in integrated glycaemia and trajectory, not in a single fasting or post-meal snapshot.

5. Mechanistic plausibility is real but the outcome link is unproven in healthy people (Tier 2–3). Acute hyperglycaemic excursions in non-diabetics measurably raise oxidative-stress (8-OHdG, ROS), inflammatory (MCP-1, TNFR1, NF-κB), and endothelial-dysfunction markers — but these are biomarker changes, and a scoping review found two studies showing no significant association between glucose spikes and adverse cardiovascular outcomes in non-diabetics (Scoping Review of Glucose Spikes in People Without Diabetes, PMC12569367, 2025). Plausible mechanism, absent outcome.

**6. The cui-bono check cuts toward the mainstream here (Tier 2). Multiple independent dietitians and endocrinologists — Oxford's Nicola Guess, Geneva University Hospitals, the McGill OSS, UCL/Birmingham researchers — independently reach the same verdict: transient spikes in healthy people are not a demonstrated harm. The same scoping review found 48 grey-literature sources versus only 11 medical studies** making spike-harm claims. The evidence weight and the money both point the same way: away from the spike-anxiety framing.

Mechanism

Why a spike is normal. Eating carbohydrate raises blood glucose; the pancreas releases insulin; glucose is taken into muscle, liver, and fat; the level returns to baseline within 2–3 hours. The peak height depends on the meal (refined carbs peak higher and faster than mixed meals), the clearance depends on insulin sensitivity. In a healthy person the peak is transient and the return is brisk — that's the system doing its job, not failing at it.

Why the pattern matters but the single peak doesn't. What predicts disease is impaired glucose tolerance: a curve that runs high and clears slowly, repeatedly, because beta-cell function and insulin sensitivity are degrading. That is what a high 1-hour OGTT or a rising HbA1c captures — an integrated, trajectory-level read of how the system handles glucose over time. A single tall peak in someone whose curve otherwise clears normally carries none of that information.

Why "flatten the curve" can mislead. Peak height is gameable in ways that have nothing to do with metabolic health. Add fat or protein to a meal and the curve flattens — not because the meal got healthier, but because gastric emptying slowed. Chasing a flat trace optimises a number with no demonstrated outcome benefit and can reward the wrong choices. The genuinely informative signal is variability and trajectory plus integrated markers, not the height of any one bump.

Why the biomarker-to-outcome leap is the weak link. Acute spikes do measurably nudge oxidative-stress and inflammation markers upward in non-diabetics — the mechanism is not fabricated. But a transient biomarker blip is not a clinical outcome, and the two studies that looked for a spike-to-CVD link in healthy people didn't find one. Mechanistic plausibility is necessary, not sufficient.

Risks And Contraindications

• Spike anxiety / orthorexia. The biggest documented harm here is psychological: CGM use in healthy people is associated with food anxiety, restriction, and disordered-eating risk. For anyone with a history of disordered eating, glucose-tracking framing is contraindicated, not helpful.
• Don't dismiss a real prediabetes signal. The flip side: someone with genuine impaired tolerance (high 1-hour OGTT, rising HbA1c, IGT risk) should be screened and managed, not reassured that "spikes don't matter." This entry corrects the healthy-person overreaction; it is not a licence to ignore a real pattern.
• People with diabetes or on glucose-lowering medication are outside this entry's "spikes are normal" framing entirely — for them postprandial control is a genuine clinical target, and medication/meal changes need clinical input.
• CGM cost and access can also entrench the wrong mental model — a healthy person watching every meal's curve is optimising a number with no demonstrated benefit and a real anxiety cost.

Controversy

Nature: a viral-marketing-driven pathologisation of normal physiology, with an overcorrection on the other side.

Position A — "Every glucose spike harms you; flatten the curve at every meal." The Glucose-Goddess/spike-anxiety take.
• Best evidence: acute spikes do nudge oxidative-stress and inflammation markers; sustained high responses genuinely predict disease.
• Where it's wrong: it transfers diabetic-population and impaired-tolerance findings onto healthy people; the harm claims for skin/mood/sleep/memory have no support in the medical literature; the "hacks" are evidenced in diabetics, not the marketed audience; and it treats peak height (gameable, uninformative) as the signal instead of trajectory and integrated markers.

Position B — "Blood sugar is a scam; spikes don't matter." The reflexive-skeptic overcorrection.
• Best evidence: transient spikes in healthy people aren't a demonstrated harm; CGM-in-healthy-people lacks an evidence base.
• Where it's wrong: a sustained or pattern of high responses, a 1-hour OGTT ≥155 mg/dL, and HbA1c variability are well-evidenced prediabetes/CVD signals. Dismissing the real impaired-tolerance signal because the spike marketing is bad is its own error.

The funding/bias dimension — cui bono, both ways. Spike-phobia is commercially load-bearing: CGM manufacturers and supplement/book sellers profit when healthy people are persuaded a normal physiological response is a disease to manage — a major CGM brand has been described as reaching near "cult status," marketed to the "health-conscious and well-off" who derive no clinical benefit. The counter-skeptic check matters too: the mainstream "spikes don't matter much in healthy people" position is held by parties with little to sell (academic dietitians, public-health endocrinologists, the McGill OSS) and is backed by the larger evidence base — 11 medical studies versus 48 grey-literature sources on the harm side. Net: follow the money toward the spike-anxiety framing, not away from it.

Realised Position: In a metabolically healthy person, a transient post-meal spike to ~140 (briefly 160–180) that clears within 2–3 hours is normal physiology, not a problem to flatten — the real signal is the trajectory and the integrated picture (HbA1c, fasting insulin/HOMA-IR, a pattern of high responses or a high 1-hour OGTT). Glucose responses genuinely matter when they reflect impaired tolerance; they do not matter as one tall bar after one meal. Don't buy the hacks, don't strap on a CGM you don't need — but don't wave away a real prediabetes pattern either.

Cross-Pillar Connections

• Diet (insulin_resistance_and_metabolic_dysfunction): owns the underlying metabolic biology — impaired tolerance, insulin resistance, the dysfunction a sustained-high-response pattern actually signals; this entry owns the interpretation question (is this spike a problem).
• Diet (blood_sugar_regulation): the lifestyle-first glycaemic levers that genuinely move HbA1c and insulin sensitivity; the protective base this entry points to instead of per-meal flattening.
• Diet (cgm_in_non_diabetics): the CGM-in-healthy-people decision and its anxiety/orthorexia cost — the device that the spike-anxiety framing wants you to wear.
• Diet (post_meal_walks_glucose): a real, free curve-modulating behaviour that also happens to be a genuinely protective habit — the honest version of "do something about glucose."
• Diet (biomarker_tracking): the integrated markers (HbA1c, fasting insulin, HOMA-IR) that actually predict outcomes — what to look at instead of a single CGM trace.

What would change our mind

Falsifiability: explicit upgrade/downgrade criteria from source

• We'd upgrade toward "transient spikes matter in healthy people" if adequately powered prospective studies linked single-meal postprandial excursions (not impaired-tolerance patterns) to hard clinical outcomes in metabolically healthy adults. Current evidence: biomarker changes only, with two studies finding no spike-to-CVD association.
• We'd rehabilitate a flattening-hack recommendation for healthy people if RCTs in non-diabetic populations showed the vinegar/mulberry/eating-order effects translate to meaningful outcomes — not just acute curve-shaving in diabetics.
• We'd revise the CGM-in-healthy-people caution if trials showed routine monitoring improved outcomes without the documented anxiety/orthorexia cost.
• What would NOT move us: the normative magnitude (~140 peak, regular 160–180 excursions in healthy people), the 1-hour-OGTT-≥155 prediabetes signal, or the fact that peak height is gameable and uninformative versus trajectory — these are settled.

Industry bias note

Structural incentives the evidence base may reflect

This is a topic where the commercial pressure is lopsided toward manufacturing the fear, which is exactly why the independent data are the anchor.
• The CGM/supplement/book end: spike-phobia is the product. CGM manufacturers, "glucose hack" books, and vinegar/mulberry/berberine sellers all profit when a healthy person is convinced a normal response is a disease. A major CGM brand reaching near "cult status," marketed to the "health-conscious and well-off" who get no clinical benefit, is the tell.
• The counter-skeptic end: smaller, but real — "blood sugar is a scam" content and anti-wellness contrarians can over-rotate and dismiss the genuine impaired-tolerance signal. Realised flags this too: the 1-hour OGTT and HbA1c-variability findings are not marketing.
• The clean anchor: academic dietitians and endocrinologists (Nicola Guess, Oxford; Geneva University Hospitals; UCL/Birmingham CGM-anxiety researchers; McGill OSS) and the independent literature — 11 medical studies versus 48 grey-literature harm sources. None of them sell a CGM, a supplement, or a flattening book. Realised weights the independent reviews and the OGTT/HbA1c outcome data over both the spike-anxiety marketing and the reflexive dismissal.

Postprandial Glucose Spikes: Normal Physiology, Not a Disease to Flatten